Fortress Biotech Analyst Ratings
Fortress Biotech Analyst Ratings
While ratings are subjective and will change, the latest Fortress Biotech (FBIO) rating was a reiterated with a price target of $0.00 to $5.00. The current price Fortress Biotech (FBIO) is trading at is $0.48, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 936.27% | Cantor Fitzgerald | → $5 | Reiterates | Overweight → Overweight |
| 05/16/2023 | 936.27% | Cantor Fitzgerald | $6 → $5 | Maintains | Overweight |
| 04/06/2023 | 936.27% | Benchmark | → $5 | Reiterates | → Speculative Buy |
| 08/04/2022 | 1143.52% | Ladenburg Thalmann | → $6 | Initiates Coverage On | → Buy |
| 07/14/2022 | 1143.52% | B. Riley Securities | $8 → $6 | Maintains | Buy |
| 04/20/2021 | 936.27% | Roth Capital | $4.5 → $5 | Maintains | Buy |
| 10/13/2020 | 884.46% | Roth Capital | $5 → $4.75 | Maintains | Buy |
| 10/12/2020 | 1972.54% | HC Wainwright & Co. | $11 → $10 | Maintains | Buy |
| 10/02/2020 | 1765.28% | Benchmark | → $9 | Initiates Coverage On | → Buy |
| 03/13/2020 | 1143.52% | B. Riley Securities | $9 → $6 | Maintains | Buy |
| 02/13/2020 | 1143.52% | Cantor Fitzgerald | → $6 | Initiates Coverage On | → Overweight |
| 12/18/2019 | 1765.28% | B. Riley Securities | → $9 | Initiates Coverage On | → Buy |
| 08/26/2019 | 3837.82% | Dawson James | → $19 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/15/2023 | 936.27% | 坎托·菲茨杰拉德 | → 5 美元 | 重申 | 超重 → 超重 |
| 05/16/2023 | 936.27% | 坎托·菲茨杰拉德 | 6 美元 → 5 美元 | 维护 | 超重 |
| 04/06/2023 | 936.27% | 基准 | → 5 美元 | 重申 | → 投机性买入 |
| 08/04/2022 | 1143.52% | 拉登堡塔尔曼 | → 6 美元 | 启动覆盖开启 | → 购买 |
| 07/14/2022 | 1143.52% | B. 莱利证券 | 8 美元 → 6 美元 | 维护 | 购买 |
| 04/20/2021 | 936.27% | 罗斯资本 | 4.5 美元 → 5 美元 | 维护 | 购买 |
| 2020 年 10 月 13 日 | 884.46% | 罗斯资本 | 5 美元 → 4.75 美元 | 维护 | 购买 |
| 2020 年 12 月 10 日 | 1972.54% | HC Wainwright & Co. | 11 美元 → 10 美元 | 维护 | 购买 |
| 2020 年 2 月 10 日 | 1765.28% | 基准 | → 9 美元 | 启动覆盖开启 | → 购买 |
| 03/13/2020 | 1143.52% | B. 莱利证券 | 9 美元 → 6 美元 | 维护 | 购买 |
| 02/13/2020 | 1143.52% | 坎托·菲茨杰拉德 | → 6 美元 | 启动覆盖开启 | → 超重 |
| 12/18/2019 | 1765.28% | B. 莱利证券 | → 9 美元 | 启动覆盖开启 | → 购买 |
| 08/26/2019 | 3837.82% | 道森·詹姆斯 | → 19 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Fortress Biotech (FBIO)?
丰泽生物科技（FBIO）的目标价格是多少？
The latest price target for Fortress Biotech (NASDAQ: FBIO) was reported by Cantor Fitzgerald on August 15, 2023. The analyst firm set a price target for $5.00 expecting FBIO to rise to within 12 months (a possible 936.27% upside). 3 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年8月15日公布了丰泽生物科技（纳斯达克股票代码：FBIO）的最新目标股价。该分析公司将目标股价定为5.00美元，预计FBIO将在12个月内上涨至936.27％（可能上涨936.27％）。去年有3家分析公司公布了评级。
What is the most recent analyst rating for Fortress Biotech (FBIO)?
丰泽生物科技（FBIO）的最新分析师评级是多少？
The latest analyst rating for Fortress Biotech (NASDAQ: FBIO) was provided by Cantor Fitzgerald, and Fortress Biotech reiterated their overweight rating.
丰泽生物科技（纳斯达克股票代码：FBIO）的最新分析师评级由坎托·菲茨杰拉德提供，丰泽生物科技重申了其增持评级。
When is the next analyst rating going to be posted or updated for Fortress Biotech (FBIO)?
丰泽生物科技（FBIO）的下一次分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fortress Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fortress Biotech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与丰泽生物技术公司的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。丰泽生物科技的最新评级是在2023年8月15日提交的，因此你应该预计下一个评级将在2024年8月15日左右公布。
Is the Analyst Rating Fortress Biotech (FBIO) correct?
分析师对丰泽生物科技（FBIO）的评级是否正确？
While ratings are subjective and will change, the latest Fortress Biotech (FBIO) rating was a reiterated with a price target of $0.00 to $5.00. The current price Fortress Biotech (FBIO) is trading at is $0.48, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的丰泽生物技术（FBIO）评级，目标股价为0.00美元至5.00美元。丰泽生物科技（FBIO）目前的交易价格为0.48美元，在分析师的预测区间内。
